Features | Partner Sites | Information | LinkXpress
Sign In
Schiller
GLOBETECH PUBLISHING LLC
Ampronix

Carotid Artery MRI May Predict Probability of Heart Attack, Stroke

By Medimaging International staff writers
Posted on 17 Mar 2014
Image: Transverse (a) T2-weighted, (b) unenhanced T1-weighted, and (c) gadolinium-enhanced T1-weighted MR images in an 82-year-old man. The left ICA wall shows no plaque or significant wall thickening. The right ICA shows plaque with a lipid core (arrow). ICA = internal carotid artery, ECA = external carotid artery, IJ = internal jugular vein (Photo courtesy of the Radiological Society of North America).
Image: Transverse (a) T2-weighted, (b) unenhanced T1-weighted, and (c) gadolinium-enhanced T1-weighted MR images in an 82-year-old man. The left ICA wall shows no plaque or significant wall thickening. The right ICA shows plaque with a lipid core (arrow). ICA = internal carotid artery, ECA = external carotid artery, IJ = internal jugular vein (Photo courtesy of the Radiological Society of North America).
Image: Transverse gadolinium-enhanced T1-weighted MR images obtained superior to the carotid artery bifurcation in a 72-year-old man. L = ICA (internal carotid artery) lumen. (a) Low-signal-intensity calcium (arrow) and lipid core (arrowheads) can be seen. (b) Note contouring of the ICA. The outer adventitial wall (red), lipid core (blue), calcification (green), and vessel lumen (purple) are visible (Photo courtesy of the Radiological Society of North America).
Image: Transverse gadolinium-enhanced T1-weighted MR images obtained superior to the carotid artery bifurcation in a 72-year-old man. L = ICA (internal carotid artery) lumen. (a) Low-signal-intensity calcium (arrow) and lipid core (arrowheads) can be seen. (b) Note contouring of the ICA. The outer adventitial wall (red), lipid core (blue), calcification (green), and vessel lumen (purple) are visible (Photo courtesy of the Radiological Society of North America).
Noninvasive magnetic resonance imaging (MRI) of carotid artery plaque can effectively forecast future cardiovascular events such as strokes and heart attacks in individuals without a history of cardiovascular disease, according to a new research.

Researchers have long known that some arterial plaque is more dangerous because of its vulnerability to rupture. MRI can distinguish facets of vulnerable plaque, such as a lipid core with a thin fibrous cap. This ability makes MRI a potentially valuable tool for identifying patients at risk for ensuing cardiovascular events.

To study the predictive benefits of MRI plaque imaging, researchers performed carotid artery ultrasound and MRI on 946 asymptomatic patients from the Multi-Ethnic Study of Atherosclerosis (MESA). The carotid arteries are very accessible for imaging, and their condition tends to reflect that of the coronary arteries that supply the heart with oxygenated blood.

The researchers, who published their findings online March 2014 in the journal Radiology, used ultrasound to evaluate carotid wall thickness and MRI to define carotid plaque composition and the remodeling index, a gauge of changes in vessel size. Imaging findings were compared with cardiovascular events, including heart attacks, stroke, and death, for an average of 5.5 years after examination.

“We studied asymptomatic individuals with a low risk of cardiovascular events at baseline and used noninvasive imaging to predict the risk of an event downstream,” said David A. Bluemke, MD, PhD, from the US National Institutes of Health Clinical Center (Bethesda, MD, USA). “This is the first population-based prospective study to determine if vulnerable plaque features by MRI add to the risk of a cardiovascular event beyond the traditional risk factors.”

Cardiovascular events occurred in 59 of the patients. Abnormal thickening of the carotid artery wall and the presence of a lipid core and calcium in the internal carotid artery on MRI were significant predictors of subsequent events. A lipid core was present in nearly half of the patients who had an event, compared with only 17.8% of those who did not have an event. “The primary factors that predicted future risk were measures of vessel wall thickness in combination with the presence or absence of a lipid core,” Dr. Bluemke said. “The presence of a lipid core was 50% more common in people who had subsequent events.”

Using MRI scanning improved the reclassification of baseline cardiovascular risk in the study group. When both the carotid remodeling index and lipid core were used for risk stratification, approximately 16% more patients with events and 7% without events were accurately reclassified compared with the use of traditional risk factors. “The results bolster the use of MRI as a surrogate marker of efficacy in therapeutic studies and point to a role in determining which patients might need more aggressive treatments,” Dr. Bluemke said. “As risk factor prediction gets better, we’ll be able to screen more intelligently and use more intensive treatments in those individuals who face a higher risk of cardiovascular events.”

Dr. Bluemke noted that sequences for plaque composition could be readily added to existing carotid MRI angiography protocols for clinical purposes. “Carotid MRI has significant advantages,” he stated. “The results are more reproducible than those of ultrasound.”

Dr. Bluemke emphasized that the availability and cost-effectiveness could restrict the use of MRI. However, ultrasound and computed tomography (CT) are practical options for screening, he noted, particularly with improvements in CT dose reduction.

Related Links:

US National Institutes of Health Clinical Center



Channels

Radiography

view channel
Image: Carestream DRX-Excel Plus Fluoroscopy Imaging System (photo courtesy of Carestream).

Carestream Enters Radiography/Fluoroscopy Sector with Two Systems

Carestream has entered the radiography/fluoroscopy market with two new imaging systems and an optional flat panel detector that can also be used for general radiography. The systems can be used to perform... Read more

Ultrasound

view channel

New Ultrasound System Enhances Patient Care and User Experience

A new ultrasound system with innovative specialized transducers and improved image quality, intended for general imaging, women’s health, and shared service applications, has been announced. The system features improved accuracy, performance, assessment tools, advanced automation, and an enhanced user experience.... Read more

Nuclear medicine

view channel

New Imaging Collaboration Could Improve Treatment and Quality of Life of Prostate Cancer Patients

A development agreement between a large medical imaging vendor and smaller medical device company promises to help promote a unique minimally invasive treatment that can ablate the prostate gland. The agreement will give the device developer access to a large installed base of Magnetic Resonance Imaging (MRI) systems,... Read more

General/Advanced Imaging

view channel
Image: Illustration of a new technique using Optical Coherence Tomography that could help surgeons differentiate a human brain tumor, red, from surrounding noncancerous tissue, green (Photo courtesy of  Carmen Kut, Jordina Rincon-Torroella, Xingde Li and Alfredo Quinones-Hinojosa/Johns Hopkins Medicine).

Imaging Technique Helps Safer and More Effective Removal of Brain Tumors

Researchers at the Johns Hopkins University have demonstrated a new imaging technology that could enable neurosurgeons to better differentiate between healthy and cancerous brain tissue and perform safer... Read more

Imaging IT

view channel
Image: The Arbor Solution M2150 medical workstation with 21.5\

Multifunction Workstation Screen Meets Critical Certification Standards for Medical Environments

A medical imaging equipment vendor has unveiled a new workstation with a 54.61 cm true flat screen designed for operating rooms, clinical stations, and Picture Archiving and Communications Systems (PACS).... Read more

Industry News

view channel

Guerbet Aims for Global Medical Imaging Leadership by Acquisition of Mallinckrodt’s CMDS Business

Guerbet (Paris, France) has announced a definitive agreement for the acquisition of the Contrast Media and Delivery Systems (CMDS) business of pharmaceutical giant Mallinckrodt (Chesterfield, Derbyshire, UK). The acquisition gave Guerbet and the CMDS unit combined pro-forma sales of nearly EUR 800 million in 2014, a... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.